Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-Forming Endothelial Cells through Inactivation of Survival Signal ERK1/2 by Kunimasa, Kazuhiro et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine





Inactivation of Survival Signal ERK1/2
KazuhiroKunimasa,1 Mok-Ryeon Ahn,1,2 Tomomi Kobayashi,1 Ryoji Eguchi,3
Shigenori Kumazawa,1 YoshihiroFujimori,4 Takashi Nakano,3 Tsutomu Nakayama,1
Kazuhiko Kaji,1 andToshiro Ohta1
1Graduate School of Nutritional and Environmental Sciences and Global COE Program, University of Shizuoka,
Shizuoka 422-8526, Japan
2Department of Food and Nutrition, Dong-A University, 840 Hadan-2 dong, Saha-gu, Busan 604-714, Republic of Korea
3Department of Thoracic Oncology, Hyogo College of Medicine, Japan
4Cancer Center, Hyogo College of Medicine, Hyogo 663-8501, Japan
Correspondence should be addressed to Toshiro Ohta, ohtat@u-shizuoka-ken.ac.jp
Received 8 October 2008; Accepted 3 March 2009
Copyright © 2011 Kazuhiro Kunimasa et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
We recently reported that propolis suppresses tumor-induced angiogenesis through tube formation inhibition and apoptosis
induction in endothelial cells. However, molecular mechanisms underlying such angiogenesis suppression by propolis have not
been fully elucidated. The aim of this study was to investigate the eﬀects of ethanol extract of Brazilian propolis (EEBP) on two
majorsurvivalsignals,extracellularsignal-regulatedkinase1/2(ERK1/2)andAkt,andtoelucidatewhetherchangesinthesesignals
were actually involved in antiangiogenic eﬀects of the propolis. Detection by western blotting revealed that EEBP suppressed
phosphorylation of ERK1/2, but not that of Akt. Pharmacological inhibition by U0126 demonstrated that ERK1/2 inactivation
alone was enough to inhibit tube formation and induce apoptosis. It was also shown that EEBP and U0126 similarly induced
activation of caspase-3 and cleavage of poly ADP-ribose polymerase (PARP) and lamin A/C, all of which are molecular markers
of apoptosis. These results indicate that inhibition of survival signal ERK1/2, and subsequent induction of apoptosis, is a critical
mechanism of angiogenesis suppression by EEBP.
1.Introduction
Propolis is a resinous substance collected by honeybees from
buds and exudates of certain trees and plants, and stored
inside their hives. It has been used in folk medicine from
ancient times to treat various ailments [1, 2]. It has been
revealed that propolis possesses various biological activities
such as antibacterial [3, 4], antifungal [3, 4], antiviral [3, 5],
anti-inﬂammatory [6] and anticancer [7–10]p r o p e r t i e s .W e
previously reported that ethanol extract of Brazilian propolis
(EEBP) suppresses tumor-induced angiogenesis in vivo and
tube formation of endothelial cells in vitro [11]. We also
demonstrated recently that propolis suppresses angiogenesis
through induction of apoptosis in endothelial cells, but
molecular mechanisms underlying induction of endothelial
cell apoptosis by propolis have not been fully elucidated
[12].
Angiogenesisisdeﬁnedastheprocessinwhichanetwork
of new blood vessels emerges from pre-existing vessels.
Angiogenesis has been shown to be essential for tumor
growth and metastasis, which are two major factors that hin-
der cancer therapy [13]. We and others have shown that food
factors, such as epigallocatechin gallate (EGCg), indole-3-
carbinol, resveratrol and quercetin, possessed antiangiogenic
properties [14–17]. Such antiangiogenic food factors could
be usedtoeﬀectively prevent small cancers from progressing.
Investigation of the eﬀects of many angiogenesis
inhibitors has revealed that one of the major antiangiogenic
mechanisms of these drugs is induction of apoptosis in
endothelial cells [18]. Apoptosis is a genetically programmed2 Evidence-Based Complementary and Alternative Medicine
form of cell death. Angiogenic stimuli such as vascular
endothelial growth factor (VEGF) and basic ﬁbroblast
growth factor (bFGF) are known to activate extracellular
signal-regulated kinase 1/2 (ERK1/2) and Akt, which trans-
duce survival signals in endothelial cells and simultaneously
prevent apoptosis by inactivating proapoptotic proteins [19–
21]. On the other hand, apoptotic stimuli are known
to activate a caspase cascade that ultimately leads to the
oligonucleosomal fragmentation of DNA and the cleavage
of proteins such as poly ADP-ribose polymerase (PARP) and
lamin A/C [22].
In this study, we investigated the eﬀects of EEBP on
endothelial cell apoptosis. We also analyzed changes in
survival signals using western blotting. We further inves-
tigated the role of ERK1/2 inactivation by the propolis
using U0126, a speciﬁc pharmacological inhibitor of ERK1/2
activation.
2.MaterialsandMethods
2.1. Materials. Medium MCDB-104 was purchased from
Nihon Pharmaceutical (Tokyo, Japan), fetal bovine serum
(FBS) from Moregate (Brisbane, Australia), Atelocollagen
Bovine Dermis (type I collagen) from Koken (Tokyo, Japan),
human bFGF (Recombinant) from Austral Biologicals (San
Ramon, CA) and U0126 from Calbiochem (La Jolla, MO).
Unless otherwise stated, all chemicals were purchased from
Sigma(StLouis, MO).Allantibodies usedinthisexperiment
were from Cell Signaling Technology (Beverly, MA). EGCg,
which was used as a positive control food factor to inhibit
angiogenesis, was a kind gift from Dr Yukihiko Hara at
Tokyo Food Techno Co., Ltd. (Tokyo, Japan) and dissolved
in sodium phosphate buﬀer (pH 6.0).
2.2. Preparation of Propolis Extract. Brazilian propolis was
c o l l e c t e di nM i n a sG e r a i sS t a t e ,w h e r eBaccharis dracun-
culifolia DC. is the main botanical source of the propolis.
Propolis sample wasextractedwith ethanol (30ml of ethanol
per gram of propolis) at room temperature for 24h as previ-
ously reported [23]. The ethanol suspension was separated
by centrifugation at 470×gf o r1 5 m i na t2 5 ◦C, and the
supernatant was concentrated in a rotary evaporator under
reduced pressure at 40◦C until reaching a constant weight,
and then redissolved in ethanol. The preparation obtained
was named ethanol extract of Brazilian propolis (EEBP), and
the color of EEBP was brown. EEBP was stored under a dry
condition at 4◦C until analyzed.
2.3. Tube Formation Assay. Human umbilical vein endothe-
lial cells (HUVECs) were grown in MCDB-104 supple-
mented with 10% FBS, 10ngml−1 EGF, 100μgml −1 heparin
and 100ngml−1 endothelial cell growth factor as previously
reported [16]. The cells were seeded on plates coated with
0.1% gelatin and allowed to grow to sub-conﬂuence at 37◦C.
Capillary tube-like structures formed by HUVECs in
collagengelwerepreparedaspreviouslydescribedwithslight
modiﬁcations [11]. Brieﬂy, HUVECs (6.0×104 cellscm−2)
were seeded in between two layers of collagen gel (0.21%
collagen) and incubated in MCDB-104 supplemented with
0.5% FBS, 10ngml−1 bFGF, 8nM phorbol 12-myristate 13-
acetate (PMA) and 25μgml −1 ascorbic acid. They were
treated with various concentrations of EEBP (0, 6.25,
12.5 and 25μgml −1), EGCg (50μgml −1) or U0126 (5μM)
for up to 36h. The tube formation was quantiﬁed by
determining the pixel number of tubes in each image
using the NIH Image program (developed at the US
National Institutes of Health and available on the Internet
at http://rsb.info.nih.gov/nih-image/).
For western blot analysis, HUVECs (2.4×105 cells per
48-well) were suspended three-dimensionally in collagen gel,
instead of being sandwiched between two layers of collagen
gel, for 12 and 24h.
2.4. Apoptosis. Observation and quantiﬁcation of apoptosis
were carried out as previously described [21]. Brieﬂy, after
experimental treatment, the cells were ﬁxed with 1% glu-
taraldehyde overnight at 4◦C and stained with 500ng/ml−1
of 4 ,6-diamidino-2-phenylindole (DAPI) overnight at
room temperature. Cells exhibiting chromatin condensation
and/or cell nuclear fragmentation were counted as apoptotic
cells. A total of more than 700 cells from six ﬁelds were
counted for each data.
2.5. Western Blot Analysis. Western blotting was carried out
as previously described [24]. Brieﬂy, the cells in collagen
gel after experimental treatment were lysed with sodium
dodecyl sulfate (SDS) sampling buﬀer (0.05M Tris–HCl
(pH 6.8), 2% SDS, 5.88% 2-mercaptoethanol, 10% glyc-
erol) with 1×protease inhibitor cocktail, 1×phosphatase
inhibitor cocktail I, 1× phosphatase inhibitor cocktail II,
1mM β-glycerophosphate and 2.5mM sodium pyrophos-
phate. Each sample was electrophoresed in a 6–12% SDS-
polyacrylamide gel under reducing conditions and then
transferred to a Hybond-ECL nitrocellulose membrane
(Amersham Biosciences, Buckinghamshire, UK). The mem-
branes were blocked for 1h with 20mM Tris-HCl, pH 7.6,
137mM NaCl and 0.1% Tween-20 containing 5% skim
milk (Snow Brand Milk Products Co., Ltd., Tokyo, Japan)
and incubated overnight at 4◦Cw i t hp r i m a r ya n t i b o d y .
Immunoreactive protein bands were visualized using an ECL
plus detection system with ECL Mini-Camera (Amersham
Biosciences).
2.6. Statistical Analysis. Results were expressed as means±
SE. Diﬀerences were ascertained by an analysis of variance
(ANOVA). Multiple comparisons among treatments were
checked with Dunnett’s test (∗P< .05, ∗∗P< .01).
3. Results
3.1. Inhibition of Tube Formation, Induction of Apoptosis
and Inactivation of ERK1/2 by EEBP. We ﬁrst investigated
whether EEBP had the ability to induce apoptosis in tube-
forming endothelial cells compared with EGCg, a well-
known tea catechin with an antiangiogenic property. As we













































































between two layers of collagen gel and induced to form blood vessel-like tubes. The tube-forming cells were treated with indicated
concentrations of EEBP or EGCg for 24h, ﬁxed and stained with DAPI. Representative photographs are shown. Bar indicates 100μm. (b)
Areas of the formed tubes (area ratios of the tubes per pictured ﬁeld) and (c) rates of apoptosis (percentage of condensed and fragmented
cell nuclei against total cell nuclei) were quantiﬁed as described in Materials and methods section. ∗P< .05, ∗∗P< .01, as compared to
the control. (d) After 12h treatment with indicated concentrations of EEBP, cellular proteins were collected from tube-forming HUVECs.
Changes in phosphorylation state of ERK1/2at Thr202/Tyr204 and Akt at Ser473 were analyzed by western blotting. Each experiment was



























Figure 2: ERK1/2 inactivation by U0126 inhibits tube formation of HUVECs. (a) After 12h treatment with U0126 (5μM) or EEBP
(25μgml −1), cellular proteins were collected from tube-forming HUVECs. Changes in phosphorylation state of ERK1/2 at Thr202/Tyr204
were analyzed by western blotting. Each experiment was repeated at least three times and representative data are shown. (b) Tube-forming
HUVECs were treated with U0126 (5μM) or EEBP (25μgml −1) for 24h. Representative photographs are shown. Bar indicates 100μm.
(c) Areas of the formed tubes were measured as described in Materials and methods section. Values are expressed as means±SE of three
independent experiments. ∗∗P< .01, as compared to the control.
on angiogenesis in vitro (Figure 1(a)). Control tube-forming
HUVECs, treated with vehicle only, formed a network of
capillary-like tubes, which were composed of multiple cells
that gathered together and adhered to each other. EEBP
reduced the width of tubes and inhibited the elongation
of tubes in a concentration-dependent manner. Concur-
rently, the propolis induced chromatin condensation and
nuclear fragmentation, morphological markers of apoptosis,
in tube-forming HUVECs in a concentration-dependent
manner. The tube areas were 41.8%, 34.0%, 29.9%, 19.9%
and 28.0% for control, EEBP (6.25, 12.5 and 25μgml −1)
and EGCg (50μgml −1 =109μM), which were calculated to
be 81%, 72%, 48% and 67% for EEBP (6.25, 12.5 and
25μgml −1) and EGCg (50μgml −1), respectively, compared
to the control (Figure 1(b)). The rates of apoptotic cells were
10.7%, 13.8%, 17.1%, 23.4% and 18.7% for control, EEBP
(6.25, 12.5 and 25μgml −1) and EGCg (50μgml −1), which
were calculated to be a 1.3-, 1.6-, 2.2- and 1.8-fold increase
forEEBP(6.25,12.5and25μgml −1)andEGCg(50μgml −1),
respectively, compared to the control (Figure 1(c)). Thus,
it was shown that EEBP at 25μgml −1 had stronger eﬀects
on tube formation inhibition and apoptosis induction than
EGCg at 50μgml −1.
In order to elucidate the molecular mechanisms respon-
sible for apoptosis induction by EEBP, we further analyzed
how survival signals, ERK1/2 and Akt, were aﬀected by the
propolis. When changes in the activation state of the survival































Figure 3: ERK1/2 inactivation by U0126 induces endothelial cell apoptosis at the cellular and molecular levels. (a) Tube-forming HUVECs
were treated with U0126 (5μM) or EEBP (25μgml −1) for 24h. The cells were ﬁxed and stained with DAPI. Representative photographs are
shown. Bar indicates 50μm. (b) Rates of apoptosis were quantiﬁed. Values are expressed as means±SE of three independent experiments.
∗P< .05, ∗∗P< .01, as compared to the control. (c) Cellular proteins were collected from tube-forming HUVECs that were treated with
U0126(5μM)orEEBP(25μgm l −1)for24h.Changesincaspase-3,PARPandlaminA/Cwereanalyzedbywesternblotting.Eachexperiment
was repeated at least three times and representative data are shown.
shown to inactivate ERK1/2 in a concentration-dependent
manner (Figure 1(d)). On the other hand, the propolis had
very little eﬀect on Akt activation.
3.2. Inhibition of Tube Formation through ERK1/2 Inacti-
vation by U0126. We next investigated whether ERK1/2
inactivation was actually involved in the regulation of tube
formation inhibition by EEBP. We used U0126, a known
speciﬁc inhibitor of mitogen-activated protein kinase/ERK
kinase 1/2 (MEK1/2), to simulate the inhibitory eﬀect of
EEBP on ERK1/2. Since MEK1/2 is known to directly
phosphorylate ERK1/2, the inhibitor eﬀectively prevents
ERK1/2 activation and its downstream signal transduc-
tion. U0126at 5μm showed a strong inhibitory eﬀect on
ERK1/2 activation, which was very close to and slightly
stronger than that of EEBP at 25μgml −1 (Figure 2(a)).
The inhibitor also moderately reduced the number of
tubes and caused partial fragmentation of the network.
EEBP seemed to have an additional inhibitory eﬀect on
tube-forming HUVECs, not only reducing the number of
tubes and causing partial fragmentation of the network but
also inhibiting the elongation of cells (Figure 2(b)). Such
observations were further conﬁrmed by quantifying tube
area. The areas were 31.3% for control, 22.5% for U0126
and 17.0% for EEBP, which were calculated to be 72%
and 54% for U0126 and EEBP, respectively, compared to
the control (Figure 2(c)). Thus, it was shown that ERK1/2
inactivation by U0126 was enough to reproduce most of
the inhibitory changes induced by EEBP in tube morphol-
ogy.
3.3. Induction of Apoptosis through ERK1/2 Inactivation by
U0126. We further investigated what role ERK1/2 inactiva-
tion played in endothelial cell apoptosis induced by EEBP. As
shown in Figure 3(a), treatment with either the inhibitor or
EEBP resulted in similar increase in the number of apoptotic
cells. The rates of apoptotic cells were 10.7% for the control,
19.1% for U0126 and 21.6% for EEBP, which were calculated
to be a 1.8- and 2.0-fold increase for U0126 and EEBP,









Figure 4: Schematic diagram of angiogenesis suppression by EEBP.
Proangiogenic factors such as bFGF and PMA stimulate ERK1/2
signaling.Subsequently, thesurvivalsignalinactivates caspasepath-
way, thereby maintaining cell survival and facilitating angiogenesis.
In contrast, EEBP inhibits ERK1/2 activation, thereby activating
caspase pathway and inducing apoptosis, which consequently leads
to angiogenesis suppression.
investigated how ERK1/2 inactivation by U0126 or by EEBP
aﬀected caspase cascade using western blotting. They both
markedly increased the amounts of cleaved forms of caspase-
3, PARP and lamin A/C to similar extents (Figure 3(c)).
Thus, it was shown that ERK1/2 inactivation by U0126
was enough to reproduce all of the apoptotic changes we
observed at both morphological and molecular levels in
tube-forming HUVECs induced by EEBP.
4. Discussion
We recently reported that propolis inhibited tube formation
and induced apoptosis in endothelial cells [12]. In this study,
to further elucidate the molecular mechanisms underlying
such antiangiogenic eﬀects of propolis, we investigated how
EEBP aﬀected two major survival signals, ERK1/2 and
Akt. We were able to show that EEBP suppressed ERK1/2
activation, but had very little eﬀect on Akt. We further
conﬁrmed that ERK1/2 inactivation was largely responsible
for antiangiogenic eﬀects, tube formation inhibition and
apoptosis induction, in endothelial cells. Figure 4 shows
proposed antiangiogenic mechanisms by EEBP.
ERK1/2 signaling in endothelial cells has been shown to
play an essential role in angiogenesis both in vivo and in
vitro. It was reported that bFGF and bone morphogenetic
protein-4 induced the formation of capillary-like structures
by endothelial cells through ERK1/2 activation [25, 26]. In
contrast, it was demonstrated that several pharmacological
inhibitors, dominant negative constructs and siRNA against
Raf/MEK/ERK pathway inhibited angiogenesis in vivo and
tube formation of endothelial cells without aﬀecting Akt
activation [27–30]. Furthermore, such inhibitors have also
been shown to induce endothelial cell apoptosis in vivo
and in vitro [31]. Our results are in line with these reports
and conﬁrm that ERK1/2 inactivation alone is suﬃcient to
prevent angiogenesis and induce apoptosis in endothelial
cells. Thus, we concluded that ERK1/2 inactivation was a
major mechanism responsible for antiangiogenic action of
EEBP.
Propolis is generally used as an alcohol or water extracts
in human applications and not as a single puriﬁed com-
pound. In addition, the chemical composition of propolis
is known to vary qualitatively and quantitatively depending
upon their geographical and botanical origins [23, 32]. Due
to such diﬀerences, biological activities of propolis also diﬀer
depending upon their origins [23, 33–35]. Hence, it is very
important to evaluate biological activities of propolis in
extracted form with speciﬁed geographical and botanical
origins and clariﬁed chemical composition [36].
In this study, we showed that EEBP inhibited ERK1/2
activation. We previously reported that Brazilian propolis,
collected from Baccharis dracunculifolia DC. in Minas Gerais
State, were composed mainly of artepillin C, caﬀeic acid
and p-coumaric acid [23, 37]. We also reported recently
thatseveralconstituentsofBrazilianandUruguayanpropolis
possessedantiangiogenicactivitieswithvaryingdegrees[38].
We would like to further investigate which constituents
of the propolis are responsible for ERK1/2 inactivation
in endothelial cells. Although EEBP and U0126 had very
similar eﬀects on tube formation inhibition and apoptosis
induction, it should be noted that the propolis exhibited
stronger antiangiogenic activities, such as inhibiting elon-
gation of endothelial cells during tube formation, than
those of U0126. Such results suggest a possibility that there
might be mechanism(s) other than ERK1/2 inactivation
in angiogenesis suppression by EEBP. We would like to
further investigate how the propolis aﬀects other signaling
pathways involved in angiogenesis and apoptosis. We hope
ourﬁndingsonantiangiogeniceﬀectsofpropoliswillhelpus
improve medical treatment and prevention of human cancer
and other angiogenesis-related diseases.
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